SingularityNET, the decentralized AI platform, has announced the launch of the Rejuve Utility Token (RJV), a novel initiative aimed at accelerating progress toward radical health span extension.
The project aims to improve human healthspan and lifespan by aggregating the data of millions of people around the world and applying innovative AI tools and methods to make longevity research accessible to everyone.
Rejuve.AI is one of SingularityNET’s earliest AI development and research initiatives and is now spinning off as a standalone project within the ecosystem to take health-oriented AI research and development to the next level.
Rejuve.AI’s novel technological and business architecture combines AI, blockchain technology, and tokenomic incentives to create a network of individuals, clinics, labs, and researchers passionate about health and longevity, empowered to produce scientific breakthroughs in life extension.
The RJV is designed to be a multi-chain utility token from the start. At the Token Generation Event, Rejuve.AI will mint 1 billion RJV tokens across two blockchains – 647,916,667 RJV-ETH tokens (64.79% of the total supply) on Ethereum and 352,083,333 RJV-ADA tokens (35.21% of the total supply) on Cardano.
RJV-ETH and RJV-ADA will be convertible on a 1:1 basis, keeping the total token supply constant at all times at 1 billion RJV – effectively allowing holders to choose which blockchain they want to use, in the same manner as SingularityNET AGIX token.
The Rejuve. AI tokenomics are designed to create shared value within the network of Rejuve.AI participants based on the primary currency and membership reward token, RJV. The tokenomic model is intended to play a major role in guiding the global healthcare system toward a more beneficial and efficient future.
The community of Rejuve token holders will form a network, and the tokens will act as a tool allowing network participants to benefit from the interaction between individuals, researchers, longevity experts, clinicians, and SingularityNET with its array of AI tools and active AI development community, along with other relevant creators of AI or other biomedically relevant tools.
